Validation of King's Sarcoidosis Questionnaire in a Danish Population
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04388085|
Recruitment Status : Recruiting
First Posted : May 14, 2020
Last Update Posted : May 14, 2020
The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health status in patients with sarcoidosis. The KSQ was previously validated in English German and Dutch.
KSQ will be translated into Danish and validated in a Danish sarcoidosis population.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Validation of King's Sarcoidosis Questionnaire in a Danish Population|
|Actual Study Start Date :||December 1, 2019|
|Estimated Primary Completion Date :||November 30, 2023|
|Estimated Study Completion Date :||November 30, 2023|
- KSQ validity in Danish [ Time Frame: 2 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04388085
|Aarhus University Hospital. Dep. of Respiatory Diseases and Allergology||Recruiting|
|Aarhus N, Denmark, 8200|
|Contact: Janne Møller, MD 0045 78462201 email@example.com|